ArticleInfection and drug resistance2025
Case Report: A Pulmonary Cryptococcosis Presenting as Interstitial Pneumonia in a Patient of IgA Nephropathy.
Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To present a rare case of pulmonary cryptococcosis that exhibited radiological findings consistent with interstitial pneumonia in a patient diagnosed with IgA (Immunoglobulin A) nephropathy. Patients and Methods: A 66-year-old man was admitted to the hospital with interstitial lung disease. The cryptococcal capsular antigen test was positive in both serum and bronchoalveolar lavage fluid. Histopathological examination of the bronchoscopically obtained lung biopsy and positive culture results revealed the presence of Cryptococcus yeast, while no Cryptococcus species were detected in the cerebrospinal fluid. Collectively, these findings confirmed the diagnosis of pulmonary cryptococcosis. Results: The fluconazole dosage was tailored according to the patient's renal function, and the lesions in the right lung were significantly improved following one month of antifungal therapy. Conclusion: This case illustrates that in immunocompromised patients, pulmonary cryptococcosis may manifest with imaging findings resembling interstitial pneumonia. Therefore, clinicians should consider pulmonary cryptococcosis in the differential diagnosis of interstitial pneumonia, particularly in immunocompromised individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.